AAFS Insider Trading Activity and SEC Form 4 Filings
AAFS insider trading summary
No open-market insider purchases or sales of Omni Bio Pharmaceutical, Inc. (AAFS) have been reported on SEC Form 4 in the past 12 months.
Latest AAFS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 28, 2009 | Vicki D E Barone | Chair of the Board | Sell | $0 (200,000 @ $0.00) |
| Apr 28, 2009 | Steven Mark Bathgate | Director | Sell | $0 (200,000 @ $0.00) |
| Mar 31, 2009 | Sarmat, LLC | Director | Buy | $90K (450,000 @ $0.20) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.